Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2019

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Type2 Diabetes
Interventions
OTHER

Exercise

16 weeks of treatment

DRUG

Liraglutide

16 weeks of Liraglutide

Trial Locations (1)

22906

RECRUITING

University of Virginia, Charlottesville

All Listed Sponsors
collaborator

American Diabetes Association

OTHER

collaborator

National Institutes of Health (NIH)

NIH

lead

University of Virginia

OTHER